Prevention of Cardiovascular Risk

Most recent articles

Prevention of Cardiovascular Complications in Dialysis Patients

Cardiovascular Risk Factors in Dialysis PatientsThe pathogenesis of cardiovascular damage in dialysis patients is far more complex than in the...

Cardiac Late Effects and Prevention Strategies for Children Treated with Anthracyclines

Mortality from anthracycline-induced cardiac failure is substantial, with some large studies reporting rates higher than 20%. 4,5 A study of 474...

Treatment of Type 2 Diabetes with a Combination of Two Insulin Sensitizers. Increased Efficacy and Fewer Side-effects

The basic principle of combination therapy is that with smaller doses of two drugs there is greater efficacy and fewer side-effects than with a large...

Fibrates - The Other Life-saving Lipid Drugs

Mechanism of Action of Fibrates Gemfibrozil and fenofibrate are the fibrates currently approved for use in the US and, in addition to these,...

Aspirin and Statins to Decrease Risks of Cardiovascular Disease - The Need for Wider Utilization

With regard to statins, in basic research these drugs decrease total and low-density lipoprotein (LDL) cholesterol as well as trigylcerides and also...

Upcoming events

ESC Congress 2010

28th August - 1st September 2010

The European Society of Cardiology (ESC) represents 59,000 cardiology professionals across Europe and the Mediterranean. The ESC comprises 5...

Copyright® 2004 - 2010 Business Briefings, Ltd. All rights reserved.
Touch Cardiology is for informational purposes and should not be considered medical advice, diagnosis or treatement recommendations.